Medical Devices

Telerad Group unveils AI-based solution for enhanced pulmonary embolism detection in radiology

Cutting-edge AI algorithm to strengthen the efficacy of ‘Made in India’ pulmonary embolism assist solution...

Revvity launches easy-to-use molecular diagnostics workflow for newborn screening

EONIS Q System enabling faster, simplified newborn screening for SMA and SCID...

BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency

SiteRite™ 9 Ultrasound System Delivers Enhanced Image Quality and Vessel Assessment Tools to Aid in First Attempt IV Insertion Success ...

Healthcare+ Expo Taiwan 2023 Showcases Cutting-edge Smart Healthcare Innovations, Facilitating Global Collaboration Opportunities

Healthcare+ Expo Taiwan 2023, the largest medical trade fair in the APAC region, is scheduled to unfold from November 30 to December 3 at the Taipei Nangang Exhibition Center. Now in its seventh edition, the exhibition is poised to exceed past scales, featuring over 2,300 booths, a 10% expansion in exhibition space, and a pioneering emphasis on more than 70 medical centers and hospitals. This positions it as the world's inaugural medical technology exhibition with a focal point on hospitals, spo...

Korea highlights golden future of wearable devices in healthcare

A novel approach to develop intelligent healthcare sensors using various gold nanowires...

Smith+Nephew acquires novel cartilage regeneration technology for sports medicine knee repair

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces that it has entered into a definitive agreement to acquire CartiHeal, developer of Agili-C, a novel sports medicine technology for cartilage regeneration in the knee. Under the terms of the agreement, Smith+Nephew will pay an initial cash consideration of $180 million at closing, and up to a further $150 million contingent on financial performance....

L&T Technology Services and NVIDIA Unveil Gen AI and Advanced Software-Defined Architecture for Medical Devices.

Collaboration Set to Enhance Medical Imaging Through Gen AI & Software-Defined Architectures...

FDA Greenlights Medtronic's Minimally Invasive Device for Hypertension Treatment

Medtronic plc a global leader in healthcare technology, announced that the United States Food and Drug Administration (FDA) has approved the Symplicity Spyral™ renal denervation (RDN) system, also known as the Symplicity™ blood pressure procedure, for the treatment of hypertension. With this approval, Medtronic will immediately begin commercialization....

Ethicon Launches ETHIZIA™ Hemostatic Patch, Clinically Proven to Halt Disruptive Bleeding

Addition of hemostatic patch complements Ethicon's comprehensive Biosurgery portfolio and ability to address critical unmet needs in controlling bleeding...